Findings reveal fluoxetine’s weak antiviral effects in COVID-19, with no significant benefits in symptom resolution compared to other antiviral treatments.
Antidepressant fluoxetine found ineffective for early COVID-19 treatment
- Post author:admin
- Post published:January 22, 2025
- Post category:uncategorized